INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 434m ago
HOUSE PTR34m ago
SEC 13F34m ago
ROBINHOOD CHAIN33m ago
Corporate insider
CN

Cox Christopher Nixon

DirectorCIK 0002008212

EDGAR filingsOpen in network
Disclosed transactions2
Buys / sells0 / 0
Max Insider Score12
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
CN
Cox Christopher NixonDirector
ANROAlto Neuroscience, Inc.
Grant or award
A—
11.0K sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Alto Neuroscience, Inc.Director · Jan 6, 2026
12
CN
Cox Christopher NixonDirector
ANROAlto Neuroscience, Inc.
Grant or award
A
$85K
7,189 sh
Jan 2, 2026
Jan 6, 2026
traded Jan 2, 2026
+4d
SEC FORM 4

Evidence